MARIE CHEN: Open Payments
NPI 1811074263 · VERONA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,499 in 106 payments from 13 companies in 2025. Trend: 2023 $1,375 · 2024 $2,027 · 2025 $2,499
Food & beverage: $2,309Education: $191
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $584 |
| GENZYME CORPORATION | 7 | $365 |
| Galderma Laboratories, L.P. | 13 | $264 |
| Regeneron Healthcare Solutions, Inc. | 5 | $262 |
| LEO Pharma Inc. | 9 | $228 |
| Lilly USA, LLC | 5 | $195 |
| Janssen Biotech, Inc. | 6 | $176 |
| PFIZER INC. | 15 | $164 |
| Incyte Corporation | 5 | $90 |
| Amgen Inc. | 4 | $76 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, NEMLUVIO, ADBRY, EBGLYSS, TREMFYA, CIBINQO.
Industry payments across NJ — which companies pay providers there.
